These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 24008390)

  • 21. Mass-Selected Site-Specific Core-Fucosylation of Serum Proteins in Hepatocellular Carcinoma.
    Yin H; Tan Z; Wu J; Zhu J; Shedden KA; Marrero J; Lubman DM
    J Proteome Res; 2015 Nov; 14(11):4876-84. PubMed ID: 26403951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis.
    Wang N; Cao Y; Song W; He K; Li T; Wang J; Xu B; Si HY; Hu CJ; Li AL
    J Gastroenterol Hepatol; 2014; 29(7):1544-50. PubMed ID: 24612022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of hepatocellular carcinoma using glycomic analysis.
    Goldman R; Ressom HW; Varghese RS; Goldman L; Bascug G; Loffredo CA; Abdel-Hamid M; Gouda I; Ezzat S; Kyselova Z; Mechref Y; Novotny MV
    Clin Cancer Res; 2009 Mar; 15(5):1808-13. PubMed ID: 19223512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies.
    Zhu J; Lin Z; Wu J; Yin H; Dai J; Feng Z; Marrero J; Lubman DM
    J Proteome Res; 2014 Jun; 13(6):2986-97. PubMed ID: 24807840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
    Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
    Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cell and hepatocyte proliferation in hepatitis C cirrhosis and hepatocellular carcinoma: transplant implications.
    Behnke MK; Reimers M; Fisher RA
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):45-53. PubMed ID: 24378265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum and tissue proteomic signatures of patients with hepatocellular carcinoma using 2‑D gel electrophoresis.
    Peng H; Yan Z; Zeng X; Zhang S; Jiang H; Huang H; Zhuo H
    Mol Med Rep; 2019 Aug; 20(2):1025-1038. PubMed ID: 31173207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.
    Nabih MI; Aref WM; Fathy MM
    Arab J Gastroenterol; 2014; 15(3-4):103-7. PubMed ID: 25249230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
    Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma and its early detection by AFP testing in Mongolia.
    Oyunsuren T; Sanduijav R; Davaadorj D; Nansalmaa D
    Asian Pac J Cancer Prev; 2006; 7(3):460-2. PubMed ID: 17059345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DKK1 in relation to HCV induced liver cirrhosis and HCV induced HCC curative resection.
    Essa ES; Montaser BA; Badawy MT; Essa AS; Mokhtar MS
    Acta Gastroenterol Belg; 2016; 79(3):309-313. PubMed ID: 27821026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fully validated SRM-MS-based method for absolute quantification of PIVKA-II in human serum: Clinical applications for patients with HCC.
    Sohn A; Kim H; Yeo I; Kim Y; Son M; Yu SJ; Yoon JH; Kim Y
    J Pharm Biomed Anal; 2018 Jul; 156():142-146. PubMed ID: 29702392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus Patients.
    Ibrahim MK; Salama H; Abd El Rahman M; Dawood RM; Bader El Din NG; Salem HF; Abdelrahim ME; Omran D; Omran MH; El-Wakeel KH; Abdelhafez TH; Khedr A; El Awady MK
    J Interferon Cytokine Res; 2016 Dec; 36(12):698-705. PubMed ID: 27726464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.
    Schwegler EE; Cazares L; Steel LF; Adam BL; Johnson DA; Semmes OJ; Block TM; Marrero JA; Drake RR
    Hepatology; 2005 Mar; 41(3):634-42. PubMed ID: 15726646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Beta-2 Microglobulin: a Possible Marker for Disease Progression in Egyptian Patients with Chronic HCV Related Liver Diseases.
    Ouda SM; Khairy AM; Sorour AE; Mikhail MN
    Asian Pac J Cancer Prev; 2015; 16(17):7825-9. PubMed ID: 26625805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma.
    Weis A; Marquart L; Calvopina DA; Genz B; Ramm GA; Skoien R
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients.
    El-Araby RE; Khalifa MA; Zoheiry MM; Zahran MY; Rady MI; Ibrahim RA; El-Talkawy MD; Essawy FM
    Cancer Gene Ther; 2020 Jun; 27(6):486-497. PubMed ID: 31316135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.